Cancer

Cathie Wood Reiterates 'Profound' AI Application In Healthcare As Researchers Discover 'Cancer Survival Outcomes' By Facial Photograph Analysis: Here Are The Stocks That Could Benefit

Bicara Therapeutics Shares Sink Over 43% On Mixed Phase 1/1b Trial Results: What's Going On?

Joe Biden Diagnosed With Advanced Prostate Cancer, Trump Wishes Former President A 'Fast And Successful Recovery'

Bicara Therapeutics Shares Sink Over 43% On Mixed Phase 1/1b Trial Results: What's Going On?

Joe Biden Diagnosed With Advanced Prostate Cancer, Trump Wishes Former President A 'Fast And Successful Recovery'

Why Is Summit Therapeutics Stock Trading Higher On Monday?

Pliant Therapeutics' Investigational Cancer Drug Shows Antitumor Activity Across Multiple Tumor Types

Why Is Summit Therapeutics Stock Trading Higher On Monday?

Pliant Therapeutics' Investigational Cancer Drug Shows Antitumor Activity Across Multiple Tumor Types

Perspective Therapeutics' Cancer-Focused Radiotherapy Portfolio Has Upside Potentional, Says Analyst

Bristol Myers Colorectal Cancer Treatment Goes Under Priority FDA Review

Cancer Recent News

Pfizer Trial For Colorectal Cancer Treatment Shows Improved Survival In Late-Stage Study

Pfizer's Braftovi combination showed significant survival benefits in a Phase 3 study for BRAF V600E-mutant metastatic colorectal cancer.

Silexion Therapeutics Highlights New Preclinical Data From Its Pancreatic Cancer Studies

Silexion Therapeutics' SIL-204 exhibits synergy with key pancreatic cancer drugs in preclinical studies. Phase 2/3 trials planned for 2026.

UK Greenlights Amgen's Drug For Aggressive Lung Cancer In Pretreated Patients

Amgen's Imdylltra gets MHRA nod for ES-SCLC after two prior therapies, offering new hope for aggressive cancer with limited treatment options.

Pyxis Oncology's Deprioritizes Second Pipeline Asset, Analyst Applauds Move

Pyxis Oncology prioritizes PYX-201 with promising Phase 1 results in solid tumors, while deprioritizing PYX-106 due to resource allocation and challenges.

FDA Rejects Johnson & Johnson's Injectable Version Of Approved Drug For Lung Cancer

The FDA delays Johnson & Johnson's SC amivantamab approval for NSCLC over facility inspection issues, unrelated to product safety or efficacy

Cannabis Extract Significantly Reduces Chemotherapy-Induced Vomiting, Tilray-Backed Study Reveals

Aura Biosciences' Bladder Cancer Candidate Demonstrates Tumor Shrinkage In Patients With High-Grade Disease

Aura Biosciences released early Phase 1 trial data on bel-sar for non-muscle-invasive bladder cancer, showing promising clinical activity and a favorable safety profile.

As Cannabis Use Grows Among Cancer Patients, Federal Agency Highlights Need For Rescheduling

Cancer patients are increasingly turning to cannabis for symptom relief, but NCI experts urge rescheduling to advance research...

Silexion Therapeutics Stock Trades Higher, Trial Data For Pancreatic Cancer Patients Shows Promise

Silexion Therapeutics sees surge in trading volume after revealing new findings from a Phase 2 trial of LODER in pancreatic cancer patients.

Ideaya Biosciences Stock Tumbles Despite Promising Data From Rare Eye Cancer Candidate

IDEAYA Biosciences released interim Phase 2 data that shows promising tumor shrinkage and eye preservation rates.

ARK Invest's Multiomics Analyst And Cathie Wood Tease Future Of Healthcare: 'Innovation Solves Problems'

ARK Invest's multiomics analyst Nemo M Despot and Cathie Wood have hinted at a revolutionary healthcare approach that leverages multiomics, artificial intelligence, and big data to diagnose and potentially cure diseases at an early stage.

What Happened With Bio-Path Stock Today?

Bio-Path shares ended Wednesday's session slightly higher after the company provided an update from its ongoing Phase 1/1b clinical trial of BP1001-A.

Turnstone Biologics Shifts Focus To 'High Unmet Medical Need' Cancers, Shares Initial Data From Colorectal Cancer Cell Therapy Study

Turnstone Biologics stock drops after Phase 1 STARLING trial data reveals mixed results for TIDAL-01 in metastatic colorectal cancer, with a 25% response rate.

Former YouTube CEO Susan Wojcicki Dies After 2-Year-Long Battle With Cancer, Sundar Pichai Pays Tribute: 'I'm One Of Countless Googlers Who Is Better For Knowing Her' (Updated)

Former YouTube CEO Susan Wojcicki has passed away from cancer, prompting heartfelt tributes from the tech industry, including a message from Google CEO Sundar Pichai.

Pfizer Settles Zantac Lawsuits, Agrees To $250M Settlement To Reduce Liability: Report

In a bid to settle thousands of lawsuits over its discontinued heartburn drug Zantac, Pfizer Inc has agreed to pay up to $250 million.

Serum Institute of India Inks Large-Scale Supply Deal For BCG Use In ImmunityBio's Bladder Cancer Combo Therapy

Unlocking global access to Bacillus Calmette-Guerin (BCG) for cancer therapy. ImmunityBio partners with Serum Institute to expand BCG supply. FDA-approved Anktiva plus BCG for bladder cancer.

Pharma's Post-Pandemic Story To Unlock A Cancer-Free Era

Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) did not only earn billions of dollars from their COVID-19 leading products but also rose to fame for saving the world from an unforeseen pandemic.

Ivanka Trump, Jill Biden, Jeff Bezos' Fiancée And Others Reach Out To Princess Kate Middleton After Shocking Cancer Diagnosis

Prominent figures, including First Lady Jill Biden and Ivanka Trump, have shown support for Kate Middleton following her unexpected cancer diagnosis announcement.

Gynecology Plays A Pivotal Role In Colorectal and Endometrial Cancer Screening

When it comes to cancer, one cannot overestimate the importance of early detection. Especially when it comes to colorectal and endometrial cancer that even big pharma companies don’t have a good track record at treating.

Enveric Biosciences Sells Cancer Patents As It Paves Way For Mental Health Treatments

Enveric Biosciences Inc. has announced the sale of a cancer-related patent portfolio, including patents and pending applications in several countries, focusing on cannabidiol as a treatment for cancer. This move allows the company to concentrate on developing novel neuropathogenic small-molecule therapeutics for mental health disorders, such as depression, anxiety, and addiction. Enveric plans to further advance its candidates EB-003 and EB-002, which target hallucinations and utilize a synthetic prodrug of psilocin. CEO Joseph Tucker expressed confidence in the deal, stating that it will enable Enveric to invest in neuroplastogens for mental health while offering strong patent protection for the undisclosed buyers, who are expected to research and develop cannabidiol-based therapies for specific cancer types.

Biden's Million Dollar Moonshot - $240 Million Is A Boon For Cancer Research, Will it be a Boost For Pharma Stocks Too?

Cannabis Commonly Used As Sleep Aid By Cancer Survivors, New Research Finds

This article was originally published by the National Organization for the Reform of Marijuana Laws (NORML) and appears here with permission. Nearly a quarter of Canadian cancer survivors acknowledge consuming cannabis as a sleep aid, according to data published in the Journal of Cancer Survivorship: Research and Practice.

Updated Lung Cancer Guidelines Acknowledge Former Smoker's Risk Of Lung Cancer Never Disappears — 5M More Americans Eligible For Screening

	
		OSZAR »